CLINICAL_TRIALS
trial_result
· 2013-04-11
Clinical Trial Update: A Study of Revlimid in the Treatment of Non-Hodgkin's Lymphoma [Phase 2]
Summary
A Phase 2 study of lenalidomide (Revlimid) for non-Hodgkin lymphoma has completed and posted results in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celgene | Conditions: Lymphoma, Non-Hodgkin's | Phase 2 | Status: COMPLETED | Results posted: 2013-04-11